Management of Metastatic GIST – What to Expect When a Tumor has Spread
This video contains information about the management of metastatic GIST presented by Dr. Aimee Crago.
Conversations with the LRG: Long-Term Survivors
On May 4th the LRG held a lively discussion with three long-term survivors, Erin McBean, John Abrams, and Dr. mOe Anderson. Diagnosed at different stages of life, with different mutations, these GISTers shared how they have thrived with GIST over ten years and counting.
It’s Time: The Life Raft Group Biomarker Testing Campaign – Outcomes
If you know your mutation, you have a better chance of getting the most effective treatment more quickly, and increasing your survival time. Knowledge makes an empowered patient and an empowered patient asks and researches their disease.
¿Qué debo hacer si presento fátiga?
"¿Qué debo hacer si presento fátiga?" aportado por Fundación GIST México.
Annual Report 2020
Our theme for 2020 was Hope. 2020 presented a challenge to us all, but most especially to our patients and caregivers who are seeking to survive this rare cancer. In 2020, The Life Raft Group needed to provide a lifeline to our community, and to offer them hope in the form of increased support as we navigate the challenges of living in a COVID-19 world. #GISTHope
It’s Time: The Life Raft Group Biomarker Testing Campaign – Effective Treatment Access
It's time to shorten the time to effective treatment access. Fundación GIST Chile shares their story.
NIH Pediatric & Wildtype GIST Clinic 2021 Applications Are Open!
The LRG will be collaborating with the NIH again in 2021 to hold the Virtual GIST Tumor Board in place of the NIH's Pediatric & Wildtype GIST Clinic normally held in the DC area. Applications to have cases reviewed are now open.
It’s Time: The Life Raft Group Biomarker Testing Campaign – Precise Diagnosis
It's time to to recognize the value of a more precise diagnosis. GISTer Jon Treder shares his story.
Welcome to our New LRG Board Members!
The Life Raft Group is delighted to welcome two phenomenal new members to our Board of Directors: Ms. Kay Stolzer and Dr. Monica (mOe) Anderson.
It’s Time: Precision Oncology
It's time to fully unleash the power of biomarker testing to support precision oncology - all GIST patients should have biomarker (mutational) testing for the best possible personalized treatment plan.